Lopinavir Completed Phase 2 Trials for Tuberculosis Infection / Human Immunodeficiency Virus (HIV) Infections Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT02415985Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly